days between the first and second procedure (n=27), and 10.4 ± 5.1 days between the second and third procedure (n=8). Mean recovery after successful intervention ranged from 9 to 19.3 days depending on the procedure (p=NS) 
days between the first and second procedure (n=27), and 10.4 ± 5.1 days between the second and third procedure (n=8). Mean recovery after successful intervention ranged from 9 to 19.3 days depending on the procedure (p=NS) . Comparisons between multiloculated and uniloculated empyemas, parapneumonic and nonparapneumonic empyemas, and culture proven and biochemically proven empyemas showed no significant difference in procedure success rates or length of hospital stay. Conclusion: Multiple therapeutic options exist for the treatment of thoracic empyema. Optimal therapy requires selection of the most appropriate first procedure for each patient with early postprocedure imaging to avoid inordinate delays between interventions.
(CHEST 1995; 107:1532-37)
MUSC=Medical University of South Carolina
Key words: chest tube; decortication; empyema; fibrinolysis; pleura; pneumonia successful. Progression to the organizational stage virtually guarantees the need for more aggressive drainage because of the extensive pleural peel that restricts lung expansion even if the fluid can be successfully drained. Because many of the infections that cause empyema are indolent, patients are often seen by a physician after their parapneumonic empyema has already reached the fibrinopurulent or organizational stage. These patients often are subjected to multiple procedures and long hospitalizations before the empyema is successfully treated. We reviewed our experience with thoracic empyema over a 44-month period at the Medical University of South Carolina (MUSC) with special attention to procedures used, success rates of each procedure, interval between procedures, length of hospitalization, and outcome. METHODS Seventy-seven patients had a medical record discharge diagnosis of thoracic empyema at the MUSC Hospital between January 1, 1989 and August 31, 1993. Seventy of the 77 charts were available for review.
Forty-five of the 70 patients had thoracic empyema confirmed by one of three criteria: (1) pleural fluid culture or Gram's stain included in the analysis because no other outcome measure was available. Demographic data for the remaining 43 patients are in Table 1 . Twenty-four of the 43 cases of thoracic empyema occurred during or after a bronchopulmonary infection (parapneumonic empyema). Of the remaining 19 cases, 4 occurred after gunshot wounds to the upper abdomen (three with transdiaphragmatic injuries), 4 occurred after seeding from an extrapulmonary source (2 after esophageal rupture, 1 after extension from a skin infection at a previous thoracotomy scar, and 1 from bacteremia), and 11 were from iatrogenic causes (9 postthoracotomy, 1 postthoracentesis, and 1 after percutaneous drainage of a liver abscess).
Most of the patients had symptoms attributable to their empyema (Table 2) , with fever being the most common symptom (28/43, 65%). The lack of symptoms in three patients could not be explained by corticosteroid use or neurologic disease. (Table   3 ).
Long-term follow-up was available on three of the five patients discharged home from the hospital with empyema tubes. Those three patients had frequent follow-up visits for an average of 105±11 days before the empyema tube was completely removed.
Utilization and success rate for each procedure are listed in Table 4 . Thrombolytics (streptokinase [7] , urokinase [1] ) were used through both large-bore chest tubes (n=6) and smaller pigtail catheters (n=2), with one success occurring with each type of catheter. The overall success rate for "nonsurgical" interventions was 27% (13/49), while surgical interventions were successful 93% of the time (28/30).
Twenty-four patients had parapneumonic and 19 had nonparapneumonic empyemas. There was no significant difference in age, initial procedure, number of procedures, success rates of each procedure, length of time between each procedure, or length of hospitalization after successful therapy between the two groups.
Multiloculated empyemas were documented in 21 of 43 (49%) patients. Tube thoracostomy, the most common first procedure in both the uniloculated and the multiloculated groups, was successful in one patient in the uniloculated group and two patients in the multiloculated group. Intrapleural thrombolytics were used in six patients with multiloculated empyemas and two patients with uniloculated empyemas, with the only successes in the multiloculated group (2/6, 33%). There was no significant difference between uniloculated and multiloculated empyemas with respect to timing of procedures, success rates of different procedures, or length of hospitalization.
Seventeen of 43 patients had a history of alcohol abuse with 12 of the 17 having parapneumonic empyemas. There was no significant difference in age, Because of the indolent nature of many infections that lead to empyema and the potential for rapid pleural fluid loculation, patients frequently come to medical attention when the pleural fluid is not free flowing and closed drainage is unlikely to be successful. This was true in our population, where all 43 patients had loculated pleural fluid at presentation. Despite the expected low success rate for tube thoracostomy in the treatment of late empyema, it remains a first-line therapy, if for no other reason than to attempt to decrease the severity of pleural sepsis until further therapy can be instituted.
With the low success rate of tube thoracostomy for loculated empyema, attention has focused on other approaches to drainage of the pleural space. One option is the use of image-directed catheters, smallbore "pigtail" catheters placed with ultrasound or CT guidance. Early reports of drainage by image-directed catheters have reported success rates ranging from 70 to 90%.2,4 Our success rate with imagedirected catheters of 57% is similar to that reported previously, with failures related to inadequate drainage or poor lung reexpansion. While this option appears favorable, the added cost of multiple CT scans and the need for multiple catheters in some patients is a potential drawback.
Intrapleural thrombolytics have been used in the treatment of thoracic empyema since the 1950s.5
Initial interest, however, waned because of unacceptable adverse effects due to impurities in the streptokinase preparation.6 With the introduction of purer forms of streptokinase in the 1980s, there has been renewed interest in the use of intrapleural thrombolytics. Several reports have documented successful drainage of multiloculated empyemas through a single chest tube with thrombolytics,6-8 with few adverse effects.9"10 Further study is needed to identify the best agent, dose and dosing interval. Proper staging of the empyema is important when using fibrinolytics, since these agents will not effectively resolve loculations once organization has begun. The number of loculations may also impact on success rates of intrapleural thrombolytics. Fibrinolysis is likely to be more successful in patients with multiloculated empyemas, where treatment is ineffective because of inadequate drainage. Fibrinolytic therapy is less likely to resolve thick-walled uniloculated empyemas, where the problem is more often incomplete reexpansion of the lung. Both successes with fibrinolytic therapy in our study occurred in multiloculated empyemas (2/6), while the two patients who received fibrinolytic therapy for uniloculated empyema required further intervention.
Thoracotomy with decortication has gained favor as primary therapy for empyema because of the realization that surgery can be safely performed at any stage of an empyema with low morbidity and mortality.1" Decortication in our review also had an excellent success rate (95%) with no associated mortality and minimal morbidity.
Thoracoscopy was not used in any of our patients. Alcohol abuse is a risk factor for thoracic empyema, primarily because of the increased incidence of aspiration pneumonia. Alfageme and colleagues15
reported a 29% incidence of alcohol abuse in their review of thoracic empyema and also noted an increased incidence of anaerobic infection in the group with a history of alcohol abuse. Our incidence of alcohol abuse (40%) was even higher than that reported by Alfageme et al. 15 Although the incidence of anaerobic infection is higher, and presumably this population of patients presents to their physician at a later time in the evolution of their empyema, we found no difference in the success rates of each procedure or in the number of procedures needed to successfully treat the empyema between patients with and without alcohol abuse.
Culture (Fig 1) . This approach focuses on early imaging of the chest once an empyema has been documented by thoracentesis, with initial therapy guided by the number of loculations. We believe the first procedure should be different for a uniloculated empyema than a multiloculated empyema, recognizing that drainage of uniloculated empyemas is usually easily accomplished, and the problem is frequently one of insufficient reexpansion of the lung. Multiloculated empyemas are more difficult to drain successfully and usually warrant a more aggressive approach. We think decortication should be considered early in any patients who are good surgical candidates, because it has a high success rate and low morbidity and mortality. Once the patient has begun treatment for thoracic empyema, it is crucial that early imaging be done to confirm adequate drainage and lung reexpansion, allowing further intervention to proceed in a timely fashion.
